HomeTXMD • NASDAQ
TherapeuticsMD Inc
add
Market news
Reuters
1 hour ago
Citigroup downgrades US equities, cuts S&P 500 target below 6000 on tariff concerns
0.049%
0.00%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 667.00K | 32.87% |
Operating expense | 979.00K | -53.67% |
Net income | 252.00K | 128.54% |
Net profit margin | 37.78 | 121.48% |
Earnings per share | — | — |
EBITDA | -212.00K | 85.45% |
Effective tax rate | -37.35% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.06M | 16.92% |
Total assets | 38.82M | -10.36% |
Total liabilities | 11.45M | -18.33% |
Total equity | 27.37M | — |
Shares outstanding | 11.57M | — |
Price to book | 0.42 | — |
Return on assets | -1.99% | — |
Return on capital | -2.26% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 252.00K | 128.54% |
Cash from operations | 12.00K | 100.15% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | 12.00K | 100.21% |
Free cash flow | -984.00K | 88.56% |
Previous close
$0.99
Year range
$0.70 - $2.44
Market cap
11.40M USD
Avg Volume
57.35K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1907
Headquarters
Website
Employees
1
